GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$5.34
Tradestie Score
56
Market Cap
$267.77M
Analyst Upside
+106.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.87
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$34.81
|
$293.03M | - | 62 | Compare |
|
OMER
Omeros Corporation
|
$10.50
|
$281.75M | 9.0 | 62 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.92
|
$275.54M | - | 60 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.85
|
$275.13M | - | 51 | Compare |
|
ABEO
Abeona Therapeutics Inc. Common Stock
|
$7.06
|
$270.75M | 7.3 | 62 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.50
|
$269.08M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$39.08
|
$256.54M | - | 62 | Compare |
More GALT Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry